Lunai Bioworks (LNAI) Shares Outstanding (Weighted Average) (2011 - 2026)

Lunai Bioworks' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $25.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 54.88% year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $25.0 million (up 54.88% YoY), while the FY2025 annual figure was $165.1 million, up 69.27% from the prior year.
• Shares Outstanding (Weighted Average) was $25.0 million for Q1 2026 at Lunai Bioworks, up from $23.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $165.1 million in Q2 2025 to a low of $5.8 million in Q4 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $52.3 million across 5 years, with a median of $52.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) slumped 89.46% in 2023, then surged 176.13% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $55.3 million in 2022, then plunged by 89.46% to $5.8 million in 2023, then soared by 176.13% to $16.1 million in 2024, then surged by 43.73% to $23.1 million in 2025, then rose by 8.07% to $25.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $25.0 million (Q1 2026), $23.1 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.